Regen BioPharma Inc (RGBP)

[cvinvestor]

I believe Dmort was referring to that figure once several products currently in the pipeline are approved. Certainly not in the next 30 days, but if RGBP had 3 cancer curing products approved by FDA, it would be even higher at that point.

We can speculate that once HemaX I is approved by FDA for clinical trials even, and Orphan Drug Status will come after as a formality, the exposure RGBP will get will skyrocket compared to now.

Then, RGBP's other product lines will get serious consideration such as dCellVax, Dr. Kesari's studies for glioma application of dCellVax IND expansion, the other BORIS studies etc. Once RGBP has one FDA approved clinical trial, then a lot of the past and past bashing will lose a leg to stand on and the company and its products as it is today will be the source of consideration more and more. Do not underestimate the esteem the Ichims have earned within the scientific community either.